Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and outcomes of midline catheters for continuous 5-FU infusion in cancer patients
jRCTs042230058Completed
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluorouracil in cancer. Primary endpoint: Incidence of Phlebitis in Continuous Intravenous 5-FU Infusion via Midline Catheter. Started Jul 2023; status: completed.
02
Drugs
fluorouracil
03
Conditions
cancer
Beyond the preview
Go deeper on jRCTs042230058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042230058.